Article Details

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98% - News Medical

Retrieved on: 2022-04-04 05:19:45

Tags for this article:

Click the tags to see associated articles and topics

Experimental siRNA therapy reduces a key driver of heart disease risk by up to 98% - News Medical. View article details on hiswai:

Excerpt

In the APOLLO trial, researchers enrolled 32 people at five medical ... Hypertension treatment during pregnancy benefits pregnant women and their ...

Article found on: www.news-medical.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo